CEO & President - Thomas G. Muehlbauer
B.S. University State of New York. Entrepreneur with 30 Years CEO and Start-up experience including acquisitions, capital formation and public market transitions.
Executive Vice President - Mark Surles, PhD
PHD, University of North Carolina. Over 20 years experience leading the growth of software, medical, life science, and Internet content companies.
Gary Pace
PHD, Massachusetts Institute of Technology. President and CEO skills in addition to Industrial and academic experience in high technology based sectors of the biotechnology, pharmaceutical, medical device, and food industries.
James Wangler
M.S. San Diego State University Jim was President and CEO of MAXIM Systems, Inc. until it was acquired by Accenture in December of 2007. Prior to MAXIM Mr. Wangler served as Chief Engineer for the ISR Directorate of SPAWAR Headquarters where he also served as the Program Manager for a $200 million Space Surveillance program.
Don Miller
Mr. Miller has been an early-stage investor, board member, and CFO with a number of startups, including SeQual, Interactive Simulations, Azron, Inc., Biosym and La Jolla Technology.
Dr. Peter Goadsby
Dr. Peter Goadsby, a neurologist, specializes in the diagnosis and treatment of headache disorders, including migraines and cluster headache and other forms of chronic daily headache. He is director of the UCSF Headache Center and one of the world's leading headache experts and researchers.
Jonathan Lakey, PhD
PHD. Director of Research and Associate Professor of Surgery at the University of California Irvine. Dr. Lakey led the Human Islet Lab at the University of Alberta, during the development of the Edmonton Protocol.
Victor K. Knutzen, MD
MD, FRCS, FRCOG, FACS. Medical Consultant. Former Clinical Professor, Obstetrics/Gynecology, and Family and Community Medicine, University of Nevada.
Charles Brockus, PhD, DVM
Clinical Medicine Advisor - Charles Brockus
DVM, PHD, DACVIM, DACVP. Clinical Pathologist, Charles River Laboratories, providing expertise for experimental design and conduct of research studies.
© 2010 Avacen Inc.
Note: The statements herein have not been evaluated by the FDA. Furthermore; AVACENTM is not intended to diagnose, cure or prevent any disease
Note: The statements herein have not been evaluated by the FDA. Furthermore; AVACENTM is not intended to diagnose, cure or prevent any disease











